Valeant, Biovail become one

MISSISSAUGA, Ontario The merger between Valeant Pharmaceuticals International and Biovail is complete, the two companies said Tuesday.

Shareholders of both companies have approved the merger, worth more than $3 billion, originally announced in June.

The combined company will take Valeant’s name.